Acne

Antimony Trisulfide - Mahonia Aquifolium Root Bark - Lycopodium Clavatum Spore


Washington Homeopathic Products
Human Otc Drug
NDC 68428-017
Acne also known as Antimony Trisulfide - Mahonia Aquifolium Root Bark - Lycopodium Clavatum Spore is a human otc drug labeled by 'Washington Homeopathic Products'. National Drug Code (NDC) number for Acne is 68428-017. This drug is available in dosage form of Pellet. The names of the active, medicinal ingredients in Acne drug includes Antimony Trisulfide - 6 [hp_C]/28g Mahonia Aquifolium Root Bark - 6 [hp_C]/28g Sepia Officinalis Juice - 6 [hp_C]/28g . The currest status of Acne drug is Active.

Drug Information:

Drug NDC: 68428-017
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Acne
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Antimony Trisulfide - Mahonia Aquifolium Root Bark - Lycopodium Clavatum Spore
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Washington Homeopathic Products
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Pellet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANTIMONY TRISULFIDE - 6 [hp_C]/28g
MAHONIA AQUIFOLIUM ROOT BARK - 6 [hp_C]/28g
SEPIA OFFICINALIS JUICE - 6 [hp_C]/28g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 02 Apr, 2010
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 14 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Washington Homeopathic Products
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0740640130018
UPC stands for Universal Product Code.
UNII:F79059A38U
VZJ9F3C3SB
QDL83WN8C2
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
68428-017-1428 g in 1 BOTTLE, PLASTIC (68428-017-14)02 Apr, 2010N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses to relieve the symptoms of acne symptoms such as pimples on the face and/or neck, usually with oily skin and often caused by poor diet.

Product Elements:

Acne antimony trisulfide - mahonia aquifolium root bark - lycopodium clavatum spore sucrose lactose antimony trisulfide antimony trisulfide mahonia aquifolium root bark mahonia aquifolium root bark sepia officinalis juice sepia officinalis juice white

Indications and Usage:

Indications indications: antimon crud warts berber aqui acne sepia indifference

Warnings:

Stop use and ask doctor if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

Dosage and Administration:

Directions adults 2 pellets every 3 hours for 2 days. then 2 pellets morning and night for 2 weeks. children: 1 pellet. repeat as necessary.

Package Label Principal Display Panel:

Principal display panel enter section text here image of bottle label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.